The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes.
source https://www.sciencedaily.com/releases/2024/11/241125195050.htm
Drought can hit almost anywhere: How five cities that nearly ran dry got
water use under control
-
Water scarcity is often viewed as an issue for the arid American West, but
the U.S. Northeast's experience in 2024 shows how severe droughts can occur
in j...
15 hours ago
No comments:
Post a Comment